MRCE for Biodefense and Emerging Infectious Diseases
MRCE for Biodefense and Emerging Infectious Diseases
批准号:
7594903
负责人:
SAMUEL L. STANLEY
金额:
$798.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-04 至 2009-02-28
中文摘要
中西部生物防御和新发传染病研究卓越区域中心
英文摘要
The Midwest Regional Center for Excellence in Biodefense and Emerging Infectious Diseases Research
(MRCE) is a consortium of leading Midwest institutions that will serve the biodefense research and training
needs for Region VII as well as parts of Ohio. The founding members of the MRCE are Washington
University in St. Louis (site of the administrative core), Case Westem Reserve University, St. Louis
University, the Midwest Research Institute, and the University of Missouri. The major objective of the MRCE
is to harness outstanding scientists from the best institutions to focus on cdtical clinical issues in biodefense
and emerging infectious diseases. Our goal is research that will have an immediate impact on the nation's
public health, and will provide the scientific base for a strong biodefense effort. The Strategic Plan for the
MRCE centers on a comprehensive multi-institutional effort on the biology of poxviruses. The conjunction of
extraordinarily strong existing programs in clinical research on smallpox vaccination and basic research on
poxviruses and innate immunity to viral infections, will allow us to answer the critical questions about the
biology of vaccinia infection, and the risks of smallpox vaccination. Our second program focuses on plague,
and will use state of the art platforms in genetics and structural biology to study the pathogenesis of Yersinia
pestis, and design a new class of antibacterial agents, the pilicides, for the treatment of plague. The
backbone of the MRCE effort are Core Facilities designed to serve the biodefense needs of Region VII and
the nation. Foremost among the Cores is the Washington University Genome Sequencing Center, the
largest sequencing center in the United States. The MRCE Strategic Plan will consolidate the high
throughput sequencing and genotyping services for all the Regional Centers for Excellence at the MRCE,
resulting in significant cost savings. Finally, the MRCE will lead the effort to recruit new investigators to
clinical and basic research in biodefense and train them in how to conduct this research safely and securely
through three distinct Career Development Programs, including a one-of-a-kind fellowship program that will
train postdoctoral fellows in the life sciences to become biosafety officers. The MRCE is uniquely positioned
to serve Region VII and the nation through an exceptional program that addresses the most immediate and
urgent national biodefense needs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An Animal Biosafety Level 3 Laboratory for Stony Brook University
-
批准号:7872073
-
项目类别:
-
资助金额:$1417.96万
-
财政年份:2010
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE Administrative Core
-
批准号:7641628
-
项目类别:
-
资助金额:$55.86万
-
财政年份:2008
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Overall Career Development
-
批准号:7641691
-
项目类别:
-
资助金额:$66.24万
-
财政年份:2008
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Immunogenetics of Smallpox Vaccination
-
批准号:7641580
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2008
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases (Development Projects)
-
批准号:7641692
-
项目类别:
-
资助金额:$62.03万
-
财政年份:2008
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:6698909
-
项目类别:
-
资助金额:$334.38万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:6908968
-
项目类别:
-
资助金额:$827.51万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:7020077
-
项目类别:
-
资助金额:$795.37万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:6797835
-
项目类别:
-
资助金额:$789.41万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:7207962
-
项目类别:
-
资助金额:$766.08万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Structure-Function of Entamoeba Alcohol Dehydrogenase 2
-
批准号:6733593
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2002
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Structure-Function of Entamoeba Alcohol Dehydrogenase 2
-
批准号:6466309
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2002
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Structure-Function of Entamoeba Alcohol Dehydrogenase 2
-
批准号:6623491
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2002
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Structure-Function of Entamoeba Alcohol Dehydrogenase 2
-
批准号:6890407
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2002
-
负责人:SAMUEL L. STANLEY
-
依托单位:
ENTAMEBA HISTOLYTICA ADH2--A NEW TARGET FOR ANTI-AMEBIC THERAPY
-
批准号:6099926
-
项目类别:
-
资助金额:$10.76万
-
财政年份:1998
-
负责人:SAMUEL L. STANLEY
-
依托单位:
ENTAMEBA HISTOLYTICA ADH2--A NEW TARGET FOR ANTI-AMEBIC THERAPY
-
批准号:6235345
-
项目类别:
-
资助金额:$9.83万
-
财政年份:1997
-
负责人:SAMUEL L. STANLEY
-
依托单位:
PROTECTIVE IMMUNITY TO ENTAMOEBA HISTOLYTICA INFECTION
-
批准号:2671354
-
项目类别:
-
资助金额:$6.47万
-
财政年份:1994
-
负责人:SAMUEL L. STANLEY
-
依托单位:
PROTECTIVE IMMUNITY TO ENTAMOEBA HISTOLYTICA INFECTION
-
批准号:2057405
-
项目类别:
-
资助金额:$6.35万
-
财政年份:1994
-
负责人:SAMUEL L. STANLEY
-
依托单位:
PROTECTIVE IMMUNITY TO ENTAMOEBA HISTOLYTICA INFECTION
-
批准号:2517109
-
项目类别:
-
资助金额:$6.43万
-
财政年份:1994
-
负责人:SAMUEL L. STANLEY
-
依托单位:
PROTECTIVE IMMUNITY TO ENTAMOEBA HISTOLYTICA INFECTION
-
批准号:2057406
-
项目类别:
-
资助金额:$6.39万
-
财政年份:1994
-
负责人:SAMUEL L. STANLEY
-
依托单位:
海外基金